Related references
Note: Only part of the references are listed.Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum
Anela Blazevic et al.
ENDOCRINE-RELATED CANCER (2018)
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame
Vincenzo Marotta et al.
ENDOCRINE-RELATED CANCER (2018)
Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Thomas A. Hope et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
Guillaume P. Nicolas et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine
Anna E. Heverhagen et al.
NEUROENDOCRINOLOGY (2018)
68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology
Simone U. Dalm et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors
Camilla B. Johnbeck et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Theranostic Perspectives in Prostate Cancer with the Gastrin Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
Berthold A. Nock et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive
Marianne Pavel et al.
NEUROENDOCRINOLOGY (2017)
Effect of hormone secretory syndromes on neuroendocrine tumor prognosis
Wouter T. Zandee et al.
ENDOCRINE-RELATED CANCER (2017)
Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements
Amit Tirosh et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review
Juntaro Matsuzaki et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
68Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis
Michael M. Graham et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
Martin Barrio et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial
Estelle C. Nijssen et al.
LANCET (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
Kjell Oberg et al.
NEUROENDOCRINOLOGY (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
Anders Sundin et al.
NEUROENDOCRINOLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
Guopei Luo et al.
ONCOLOGY LETTERS (2017)
Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma
Michaela Bowden et al.
ONCOTARGET (2017)
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
David L. H. Chan et al.
THERANOSTICS (2017)
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach
Rudolf A. Werner et al.
THERANOSTICS (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Prognostic significance of neutrophil-lymphocyte ratios in large cell neuroendocrine carcinoma
Masayuki Okui et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2017)
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
Nicholas W. Bellono et al.
CELL (2017)
Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors
R. C. S. van Adrichem et al.
ANNALS OF ONCOLOGY (2016)
Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms
Mohid S. Khan et al.
CLINICAL CANCER RESEARCH (2016)
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
Anna Karpathakis et al.
CLINICAL CANCER RESEARCH (2016)
Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours
P. J. Monaghan et al.
CLINICAL ENDOCRINOLOGY (2016)
Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors
K. Kamp et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
L. Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Histopathology of NET: Current concepts and new developments
Anja M. Schmitt et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Expression of somatostatin receptors 2 and 5 in lecirculating tumour cells from patients with neuroendocrine tumours
Alexa Childs et al.
BRITISH JOURNAL OF CANCER (2016)
Algorithmic Approach to Neuroendocrine Tumors in Targeted Biopsies: Practical Applications of Immunohistochemical Markers
Kai Duan et al.
CANCER CYTOPATHOLOGY (2016)
Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients
Wei Qiu et al.
CLINICAL ENDOCRINOLOGY (2016)
MicroRNAs associated with small bowel neuroendocrine tumours and their metastases
Helen C. Miller et al.
ENDOCRINE-RELATED CANCER (2016)
Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours
Wouter T. Zandee et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Development of effective prophylaxis against intraoperative carcinoid crisis
Eugene A. Woltering et al.
JOURNAL OF CLINICAL ANESTHESIA (2016)
C-Reactive Protein as a New Prognostic Factor for Survival in Patients With Pancreatic Neuroendocrine Neoplasia
Dominik Wiese et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites
Samira M. Sadowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Non-invasive screening for neuroendocrine tumors-Biogenic amines as neoplasm biomarkers and the potential improvement of gold standards
Natalia Miekus et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets
Ellinor Andersson et al.
MODERN PATHOLOGY (2016)
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Roni Lehmann-Werman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies
Irvin M. Modlin et al.
SURGERY (2016)
Mechanosensory Signaling in Enterochromaffin Cells and 5-HT Release: Potential Implications for Gut Inflammation
Andromeda Linan-Rico et al.
FRONTIERS IN NEUROSCIENCE (2016)
Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement
Joanne E. Adaway et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2016)
Raised circulating Neurokinin A predicts prognosis in metastatic small bowel neuroendocrine tumours. Lowering Neurokinin A indicates improved prognosis
Joy E. S. Ardill et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2016)
The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract
I. M. Modlin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach
Malcolm H. Squires et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
AACE/ACE DISEASE STATE CLINICAL REVIEW: PANCREATIC NEUROENDOCRINE INCIDENTALOMAS
Miguel F. Herrera et al.
ENDOCRINE PRACTICE (2015)
The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases
Xu Han et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy
Jaroslaw B. Cwikla et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
Shreya Mehta et al.
MEDICINE (2015)
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study
Tarik Salman et al.
CHEMOTHERAPY (2015)
Chemosensory Functions for Pulmonary Neuroendocrine Cells
Xiaoling Gu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
A Single Institution's 26-Year Experience With Nonfunctional Pancreatic Neuroendocrine Tumors A Validation of Current Staging Systems and a New Prognostic Nomogram
Trevor A. Ellison et al.
ANNALS OF SURGERY (2014)
Pancreastatin Predicts Survival in Neuroendocrine Tumors
Scott K. Sherman et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection
Irvin M. Modlin et al.
ENDOCRINE-RELATED CANCER (2014)
Circulating Tumor Cells in Patients with Neuroendocrine Neoplasms
M. Ehlers et al.
HORMONE AND METABOLIC RESEARCH (2014)
Parathyroid Hormone-Related Peptide (PTHrP) Secretion by Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Clinical Features, Diagnosis, Management, and Follow-Up
Kimberly Kamp et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Prognostic Stratification of Metastatic Gastroenteropancreatic Neuroendocrine Neoplasms by 18F-FDG PET: Feasibility of a Metabolic Grading System
Samer Ezziddin et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?
Duygu Has Simsek et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Elevated Pancreatic Polypeptide Levels in Pancreatic Neuroendocrine Tumors and Diabetes Mellitus Causation or Association?
Jessica E. Maxwell et al.
PANCREAS (2014)
Tumor clone dynamics in lethal prostate cancer
Suzanne Carreira et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors
Irvin M. Modlin et al.
ENDOCRINE CONNECTIONS (2014)
Overexpression of Membrane Proteins in Primary and Metastatic Gastrointestinal Neuroendocrine Tumors
Jennifer C. Carr et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type
Sona Balogova et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours
Stefano Severi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis
Hakan Geijer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Low Accuracy of Tumor Markers for Diagnosing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Patients
Joanne M. de Laat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
Mohid S. Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Serum pancreastatin: The next predictive neuroendocrine tumor marker
Sapna Rustagi et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
Su-Chen Li et al.
MODERN PATHOLOGY (2013)
A Single Fasting Plasma 5-HIAA Value Correlates With 24-Hour Urinary 5-HIAA Values and Other Biomarkers in Midgut Neuroendocrine Tumors (NETs)
Maria R. Tellez et al.
PANCREAS (2013)
The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
Irvin M. Modlin et al.
PLOS ONE (2013)
Correction: Temporal Expression of Pelp1 during Proliferation and Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells
Jing Wang et al.
PLoS One (2013)
Identification of Candidate Serum Proteins for Classifying Well-Differentiated Small Intestinal Neuroendocrine Tumors
Spyros Darmanis et al.
PLOS ONE (2013)
Metabonomic profiling: A novel approach in neuroendocrine neoplasias
James M. Kinross et al.
SURGERY (2013)
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Emanuel Christ et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Ectopic acromegaly due to growth hormone releasing hormone
Ali A. Ghazi et al.
ENDOCRINE (2013)
Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
George Kanakis et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
The Zollinger-Ellison Syndrome: Dangers and Consequences of Interrupting Antisecretory Treatment
Pierre Poitras et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Metastatic Neuroendocrine Carcinoma Presenting as a Superscan'' on 68Ga-DOTANOC Somatostatin Receptor PET/CT
Niraj Naswa et al.
CLINICAL NUCLEAR MEDICINE (2012)
Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?
Thomas Walter et al.
EUROPEAN JOURNAL OF CANCER (2012)
Elevated Peripheral Blood Plasma Concentrations of Tie-2 and Angiopoietin 2 in Patients with Neuroendocrine Tumors
Gabriela Melen-Mucha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients
Wen-Chi Chou et al.
NEUROENDOCRINOLOGY (2012)
A Prospective Evaluation of the Effect of Chronic Proton Pump Inhibitor Use on Plasma Biomarker Levels in Humans
Daniel Raines et al.
PANCREAS (2012)
Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasms
Anne E. Diebold et al.
SURGERY (2012)
Diagnosis of Zollinger-Ellison syndrome: Increasingly difficult
Tetsuhide Ito et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
PET-Guided Surgery — High Correlation between Positron Emission Tomography with 11C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours
Håkan Örlefors et al.
Cancers (2012)
Risk Factors for the Development and Progression of Carcinoid Heart Disease
Sanjeev Bhattacharyya et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors
Mohid S. Khan et al.
CLINICAL CANCER RESEARCH (2011)
Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour
Roy Eldor et al.
CLINICAL ENDOCRINOLOGY (2011)
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors
Wiebke Arlt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
Damian Wild et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Evaluation of 177Lu-DOTA-sst2 Antagonist Versus 177Lu-DOTA-sst2 Agonist Binding in Human Cancers In Vitro
Renzo Cescato et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies
Rafael Molina et al.
TUMOR BIOLOGY (2011)
Hepatic Metastases From Neuroendocrine Tumors With a Thin Slice Pathological Examination They are Many More Than You Think ...
Dominique Elias et al.
ANNALS OF SURGERY (2010)
Angiopoietin-2 Promotes Disease Progression of Neuroendocrine Tumors
Katharina M. Detjen et al.
CLINICAL CANCER RESEARCH (2010)
The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors
Nicte Figueroa-Vega et al.
ENDOCRINE-RELATED CANCER (2010)
68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors
Alexander R. Haug et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
Tina Binderup et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
A Systematic Review of Diagnostic Procedures to Detect Midgut Neuroendocrine Tumors
Marco Scarpa et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression
Katharina Ruebel et al.
MODERN PATHOLOGY (2010)
A Nomogram to Assess Small-Intestinal Neuroendocrine Tumor ('Carcinoid') Survival
Irvin M. Modlin et al.
NEUROENDOCRINOLOGY (2010)
Principal Component Analysis, Hierarchical Clustering, and Decision Tree Assessment of Plasma mRNA and Hormone Levels as an Early Detection Strategy for Small Intestinal Neuroendocrine (Carcinoid) Tumors
Irvin M. Modlin et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis
R. Srirajaskanthan et al.
ENDOCRINE-RELATED CANCER (2009)
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours
Alexander Haug et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas
Emanuel Christ et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
Philip E. Cryer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Chromogranin-A and N-Terminal Pro-Brain Natriuretic Peptide: An Excellent Pair of Biomarkers for Diagnostics in Patients With Neuroendocrine Tumor
Catharina M. Korse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas
Justyna Leja et al.
MODERN PATHOLOGY (2009)
Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease
Sanjeev Bhattacharyya et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors
Sirianong Namwongprom et al.
ANNALS OF NUCLEAR MEDICINE (2008)
Concordance between results of somatostatin receptor scintigraphy with In-111-DOTA-DPhe(1)-Tyr(3)-octreotide and chromogranin A assay in patients with neuroendocrine tumours
Margarida Rodrigues et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
The diagnosis of Cushing's syndrome: An endocrine society clinical practice guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography
Klaas P. Koopmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
6-L-F-18-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: Basic aspects and emerging clinical applications
Pieter L. Jager et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
PET versus SPECT: strengths, limitations and challenges
Arman Rahmim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2008)
Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours
Anouk N. A. van der Horst-Schrivers et al.
EUROPEAN JOURNAL OF CANCER (2007)
The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract
V. Formica et al.
BRITISH JOURNAL OF CANCER (2007)
Measurements of chromogranin B can serve as a complement to chromogranin A
Mats Stridsberg et al.
REGULATORY PEPTIDES (2007)
Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours
G. B. Turner et al.
GUT (2006)
Serum gastrin in Zollinger-Ellison Syndrome - I. Prospective study of fasting serum gastrin in 309 patients from National Institutes of Health and Comparison with 2229 cases from the literature
Marc J. Berna et al.
MEDICINE (2006)
Serum gastrin in Zollinger-Ellison Syndrome - II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and Comparison with 537 cases from hte literature. Evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features
Marc J. Berna et al.
MEDICINE (2006)
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
Claudia Roldo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gastrointestinal carcinoids: The evolution of diagnostic strategies
Irvin M. Modlin et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and computed tomography
H Orlefors et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors
F Panzuto et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)
The diagnosis and medical management of advanced neuroendocrine tumors
GA Kaltsas et al.
ENDOCRINE REVIEWS (2004)
Gastrin: an analytical review
A Varro et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2003)
Serum peptide profiles in patients with carcinoid tumors
K Calhoun et al.
AMERICAN JOURNAL OF SURGERY (2003)
Carcinoid heart disease -: The role of urinary 5-hydroxyindoleacefic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-β and fibroblast growth factor
JM Zuetenhorst et al.
CANCER (2003)
The pathophysiological consequences of somatostatin receptor internalization and resistance
LJ Hofland et al.
ENDOCRINE REVIEWS (2003)
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative
PM Bossuyt et al.
CLINICAL CHEMISTRY (2003)
Distribution of pancreatic polypeptide and peptide YY
E Ekblad et al.
PEPTIDES (2002)
Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy
S Sanduleanu et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Standardisation of imaging in neuroendocrine tumours: results of a European delphi process
J Ricke et al.
EUROPEAN JOURNAL OF RADIOLOGY (2001)
Clinical significance of blood chromogranin A measurement in neuroendocrine tumours
E Seregni et al.
ANNALS OF ONCOLOGY (2001)
Duodenal somatostatinoma: A case report and review of 31 cases with special reference to the relationship between tumor size and metastasis
S Tanaka et al.
PATHOLOGY INTERNATIONAL (2000)
Demonstration of [C-11] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography
A Sundin et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Tumor markers in neuroendocrine tumors
B Eriksson et al.
DIGESTION (2000)
Share Paper
